BioSpace News Archive

Wireless brain sensors are devices that help monitoring the temperature, detecting the intracranial pressure, and record brain signaling in the form of brain waves.

Beckman Coulter announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo.

ONO PHARMA USA, INC. announced the appointment of David Trexler as Chief Commercial Officer of OPUS.

CB Scientific. Inc. today announces the official launch of the “Heart Wellness Check-Up” program in Bangkok, Thailand through their authorized distributor Mango Wellness and My Cardia Thailand.

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline, with Pfizer and Shionogi as shareholders, announced an exclusive collaboration and license agreement with Shionogi & Co. Ltd. for S-365598, a third-generation investigational integrase strand transfer inhibitor with potential for use in ultra long-acting HIV regimens.

Eli Lilly and Company will lower the list price of Insulin Lispro Injection in the U.S. by an additional 40 percent effective January 1, 2022, effectively bringing the list price down to 2008 levels.

Silence Therapeutics plc announced that the Company will participate in a fireside chat at the Chardan Virtual Genetic Medicines Conference on Tuesday, October 5th at 8:30 a.m.

Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced the receipt of a $2.7 million payment under its existing contract with the Cancer Prevention and Research Institute of Texas.

Gamida Cell Ltd. today announced that it will host a virtual event detailing the company’s proprietary NAM-enabled natural killer (NK) cell therapy pipeline on Tuesday, October 26, 2021 at 8:00 a.m. ET.

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat at the Chardan 5th Annual Genetic Medicines Conference.